This ATMP Summit: The importance of advanced therapies in today’s context is an EATRIS Portugal Spotlight event, organised by Centre for Neuroscience and Cell Biology (CNC-UC), Instituto Pedro Nunes (IPN), Unidade Local de Saúde de Coimbra (ULS Coimbra), Instituto de Biologia Experimental e Tecnológica (iBET) and CoLAB AccelBio (Laboratório Colaborativo AccelBio). GeneT is also supporting and organizing the event.
On November 17, Coimbra will host the ATMP Summit, The meeting will take place at the Pedro Nunes Institute (IPN) between 9:00 a.m. and 7:30 p.m., focusing on the development and impact of advanced therapies based on genes, tissues, or cells.
Under the theme The importance of advanced therapies in the current context, the meeting will welcome 16 national and international speakers from academia and regulatory bodies in the fields of health and industry, such as the vice president of INFARMED, Carlos Lima Alves, and researchers Sheila Mikhail and Jude Samulski, who are involved in gene therapy.
The sessions will focus on the latest scientific advances in Portugal in translational research, innovation, manufacturing, regulation, and future guidelines for advanced therapy medicines. Alongside the debate on the main challenges and opportunities in the area, an exhibition of companies will highlight the Portuguese industry active in this field, with the presence of several companies.
The ATMP Summit will bring together researchers, biotechnology companies, regulators, doctors, patient representatives, and the public. The event aims to promote knowledge exchange, collaboration, and real-world impact, reinforcing Portugal's role in the European ecosystem of innovative therapies. Participation is free, but subject to prior registration.
The president of the Center for Neuroscience and Cell Biology at UC (CNC-UC) and GeneT: Center of Excellence in Gene Therapy, Luís Pereira de Almeida; the director of Innovation at IPN, Jorge Pimenta; Ricardo Silva, researcher at the Institute of Experimental and Technological Biology (iBET); Sílvia Almeida, Scientific Director of AccelBio; and Patrícia Dias, coordinator of the Clinical Trials Center of the Coimbra Local Health Unit, are other speakers at the event, representing organizations that are part of the European consortium EATRIS.
The ATMP Summit is held in the context of EATRIS Spotlight, a year-long program dedicated to showcasing the best in translational medicine in Portugal, following the country's accession to the European entity EATRIS in July 2019. The event in Coimbra is co-organized by CNC-UC and the national entities of the consortium.
This one-day hybrid summit brings together researchers, biotech companies, regulators, clinicians, and patient advocates to explore the development and impact of Advanced Therapy Medicinal Products (ATMPs). The program includes sessions on the latest scientific advances, translational research, innovation and manufacturing, regulation and access, and future directions in ATMPs.
Speakers from academia, industry, and healthcare will discuss key challenges and opportunities, while an industry showcase highlights Portuguese companies active in the field. More info in Portuguese here.
The event promotes knowledge exchange, collaboration, and real-world impact, reinforcing Portugal’s role in the European ATMP ecosystem.
Registration closed.
Gallery
